Orthopedic Robots Have Promising Future
Robots from Stryker and Zimmer Biomet are worth a look.
Editor's note: At the time of publication (Dec. 11, 2019), a family member of the analyst owned shares in Stryker (SYK) in an account managed by a third party. Morningstar has confirmed that her ownership of Stryker did not influence any ratings or analysis.
Debbie Wang: With robots hitting the mainstream in orthopedic joint reconstruction, we’ve taken a closer look at the technology and key competitors that generally enjoy wide economic moats due to high switching costs.
Debbie Wang does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.